Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris

International Immunology

Volumn 23, Issue 6, 2011, Pages 365-373

  Yokoyama, Tomoaki ^a   Matsuda, Satoshi ^a,b   Takae, Yujiro ^a   Wada, Naoko ^a   Nishikawa, Takeji ^a   Amagai, Masayuki ^a   Koyasu, Shigeo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoantibodies; Autoimmunity; Skin; T cells; Tolerance suppression anergy

Indexed keywords

ANTIGEN; AUTOANTIBODY; DESMOGLEIN 3; IMMUNOGLOBULIN G; RAG2 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL TRANSFER; CLINICAL EXAMINATION; CONTROLLED STUDY; HUMAN; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PEMPHIGUS VULGARIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; REGULATORY T LYMPHOCYTE; SPLEEN CELL;

EID: 79957810681     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr020     Document Type: Article

References (40)

1. Amagai, M., Klaus-Kovtun, V. and Stanley, J. R. 1991. Autoanti-bodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869.
2. Ishii, K., Amagai, M., Hall, R. P. et al. 1997. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J. Immunol. 159:2010.
3. Anhalt, G. J., Labib, R. S., Voorhees, J. J., Beals, T. F. and Diaz, L. A. 1982. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306:1189.
4. Amagai, M., Hashimoto, T., Shimizu, N. and Nishikawa, T. 1994. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J. Clin. Invest. 94:59.
5. Amagai, M., Tsunoda, K., Suzuki, H., Nishifuji, K., Koyasu, S. and Nishikawa, T. 2000. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J. Clin. Invest. 105:625.
6. Aoki-Ota, M., Tsunoda, K., Ota, T. et al. 2004. A mouse model of pemphigus vulgaris by adoptive transfer of naïve splenocytes from desmoglein 3 knockout mice. Br. J. Dermatol. 151:346.
7. Ohyama, M., Amagai, M., Tsunoda, K. et al. 2002. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris. J. Invest. Dermatol. 118:199.
8. Tsunoda, K., Ota, T., Suzuki, H. et al. 2002. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris. Eur. J. Immunol. 32:627.
9. Takahashi, H., Amagai, M., Nishikawa, T., Fujii, Y., Kawakami, Y. and Kuwana, M. 2008. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. J. Immunol. 181:1526.
10. Nishifuji, K., Amagai, M., Kuwana, M., Iwasaki, T. and Nishikawa, T. 2000. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J. Invest. Dermatol. 114:88.
11. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531.
12. Wildin, R. S., Ramsdell, F., Peake, J. et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18.
13. Bennett, C. L., Christie, J., Ramsdell, F. et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20.
14. Chatila, T. A., Blaeser, F., Ho, N. et al. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106:R75.
15. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
16. + regulatory T cells. Nat. Immunol. 4:330.
17. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969.
18. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212:8.
19. + T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J. Immunol. 171:4604.
20. + regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J. Immunol. 175:4255.
21. + T cells selectively kill B lymphocytes. Blood 107:3925.
22. + regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. J. Immunol. 181:4447.
23. high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris. Dermatology 214:210220.
24. Chen, L., Peterson, J. D., Zheng, W., Lin, S. and Chan, L. S. 2006. Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells. Clin. Exp. Immunol. 145:322.
25. + regulatory T cells in bullous pemphigoid. Exp. Dermatol. 16:13.
26. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301.
27. Apostolou, I., Sarukhan, A., Klein, L. and von Boehmer, H. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:756.
28. van Santen, H., Benoist, C. and Mathis, D. 2004. Number of Treg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200:1221.
29. Koch, P. J., Mahoney, M. G., Ishikawa, H. et al. 1997. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J. Cell Biol. 137:1091.
30. + and CD25-regulatory T cells. J. Immunol. 176:4748.
31. + T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naïve T cells. J. Immunol. 180:7305.
32. + T cell lymphopenia-induced proliferation. Eur. J. Immunol. 39:1544.
33. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168:5979.
34. Veldman, C. M., Gebhard, K. L., Uter, W. et al. 004. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J. Immunol. 172:3883.
35. Veldman, C., Hohne, A., Dieckmann, D., Schuler, G. and Hertl, M. 2004. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J. Immunol. 172:6468.
36. + regulatory T cells. Immunity 27:493.
37. + regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J. Immunol. 173:236.
38. Seddon, B. and Mason, D. 1999. Peripheral autoantigen induces regulatory Tcells that prevent autoimmunity. J. Exp. Med. 189:877.
39. + regulatory T cells. Blood 107:1056.
40. Ota, T., Aoki-Ota, M., Tsunoda, K., Nishikawa, T., Koyasu, S. and Amagai, M. 2008. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance. Int. Immunol. 20:1351.